academic article

• Health phenome of Parkinson's patients reveals prominent mood-sleep cluster..  Research square.  2023
• Analysis of α-synuclein species enriched from cerebral cortex of humans with sporadic dementia with Lewy bodies..  Brain communications.  2:-. 2020
• β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson's disease..  Science (New York, N.Y.).  357:891-898. 2017
• Massachusetts Alzheimer's Disease Research Center: progress and challenges..  Alzheimer's & dementia : the journal of the Alzheimer's Association.  11:1241-5. 2015
• Association between α-synuclein blood transcripts and early, neuroimaging-supported Parkinson's disease..  Brain : a journal of neurology.  138:2659-71. 2015
• A highly sensitive novel immunoassay specifically detects low levels of soluble Aβ oligomers in human cerebrospinal fluid..  Alzheimer's research & therapy.  7:-. 2015
• Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study..  Neurology.  81:1531-7. 2013
• Plasma amyloid-β as a predictor of dementia and cognitive decline: a systematic review and meta-analysis..  Archives of neurology.  69:824-31. 2012
• Relation between insulin, insulin-related factors, and plasma amyloid beta peptide levels at midlife in a population-based study..  Alzheimer disease and associated disorders.  26:50-4. 2012
• Association of SNCA with Parkinson: replication in the Harvard NeuroDiscovery Center Biomarker Study..  Movement disorders : official journal of the Movement Disorder Society.  26:2283-6. 2011
• Plasma beta-amyloid level, cognitive reserve, and cognitive decline..  JAMA.  305:1655; author reply 1655-6. 2011
• Ten-year change in plasma amyloid beta levels and late-life cognitive decline..  Archives of neurology.  66:1247-53. 2009
• Amyloid deposition is associated with impaired default network function in older persons without dementia..  Neuron.  63:178-88. 2009
• A profile of impaired insulin degradation in relation to late-life cognitive decline: a preliminary investigation..  International journal of geriatric psychiatry.  24:177-82. 2009
• Performance characteristics of plasma amyloid-beta 40 and 42 assays..  Journal of Alzheimer's disease : JAD.  16:277-85. 2009
• Plasma C-peptide levels and rates of cognitive decline in older, community-dwelling women without diabetes..  Psychoneuroendocrinology.  33:455-61. 2008
• Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease..  The Journal of clinical investigation.  112:415-22. 2003